40 Stocks Moving In Tuesday's Mid-Day Session

Loading...
Loading...

Gainers

  • Audentes Therapeutics Inc BOLD shares jumped 105.9% to $58.90 after the company agreed to be acquired by Astellas Pharma for $60 per share in cash.
  • DarioHealth Corp. DRIO gained 57.9% to $7.91 after the company reported the launch of Dario-powered digital diabetes program on Walmart.com.
  • ViewRay, Inc. VRAY shares rose 31.8% to $4.48 after the company announced it has signed a memorandum of understanding for collaboration with Elekta AB and Medtronic. The company also announced a $75 million common stock offering.
  • Calyxt, Inc. CLXT gained 25% to $4.5563.
  • Akerna Corp. KERN surged 17.7% to $10.66.
  • uniQure N.V. QURE rose 15.1% to $63.03 after analysts from Goldman Sachs and Cowen & Co initiated coverage on the company's stock with bullish ratings.
  • Lands' End, Inc. LE shares gained 13.9% to $13.40 after reporting upbeat Q3 earnings.
  • Axsome Therapeutics, Inc. AXSM shares rose 13.4% to $44.94 after the company disclosed that AXS-12 achieved primary endpoint in concert Phase 2 trial in narcolepsy.
  • REGENXBIO Inc. RGNX jumped 11.4% to $45.32.
  • Kodiak Sciences Inc. KOD gained 9.5% to $55.89. In Monday’s regular session, the company announced the sale of future royalties on KSI-301 to Baker Bros. Advisors for $225 million. Shares spiked roughly 70% during regular trading. In Tuesday’s after-hours session, the company announced a $250 million common stock offering.
  • Harmony Gold Mining Company Limited HMY rose 9% to $3.225 amid US-China trade uncertainty after Trump implied a deal many not be reached until 2020. Continuing trade war concerns have led investors into 'safe-haven' assets such as gold and silver.
  • Sibanye Gold Limited SBGL rose 8.2% to $8.74.
  • Arrowhead Pharmaceuticals, Inc. ARWR gained 8% to $68.45. Arrowhead Pharmaceuticals said it intends to offer 4 million shares of its common stock in an underwritten public offering.
  • Sangamo Therapeutics, Inc. SGMO climbed 8.1% to $11.56 in sympathy with Audentes Therapeutics after the company announced it will be acquired by Astellas Pharma for $60 per share in cash.
  • Sorrento Therapeutics, Inc. SRNE shares rose 7% to $3.65.
  • Amneal Pharmaceuticals Inc AMRX gained 6% to $4.07 after the company reported the FDA approval and launch of generic carafate.
  • AK Steel Holding Corporation AKS rose 3.6% to $2.99 after Cleveland-Cliffs announced plans to acquire the company for $3.36 per share.


Check out these big penny stock gainers and losers

Losers

  • ASLAN Pharmaceuticals Limited ASLN shares dipped 46.7% to $2.77 after the company priced a 5.2 million ADS offering at $2.50 per ADS.
  • CBL & Associates Properties, Inc. CBL fell 30.3% to $0.9414 after announcing the suspension of common and preferred stock dividends. The company says it sees a decline in net operating income as a result of ‘heightened retailer bankruptcies, restructurings and store closings in 2019.’
  • Cara Therapeutics, Inc. CARA dropped 27.6% to $18.73 after the company reported mixed results from its Phase 2 trial of Oral Korsuva in chronic kidney disease patients with moderate-to-severe pruritus.
  • Aldeyra Therapeutics, Inc. ALDX dipped 26.8% to $5.48 after the company announced positive top-line results from Part 1 of the adaptive Phase 3 study dubbed RENEW, which evaluated ADX-102 (topical ocular reproxalap) for dry eye syndrome. ADX-102 was found statistically superior to vehicle in Ocular Discomfort &4-Symptom Questionnaire ocular endpoints for dryness, discomfort, burning, grittiness and stinging. For the co-primary endpoint of fluorescein nasal region ocular staining, it did not reach statistical significance.
  • Protagonist Therapeutics, Inc. PTGX dropped 26.6% to $6.50 after the company reported preliminary Phase 2 results with hepcidin mimetic PTG-300 in the treatment of transfusion dependent beta-thalassemia.
  • Eyenovia, Inc. EYEN fell 15.2% to $3.41.
  • Liquid Media Group Ltd. YVR dipped 13.8% to $2.9652.
  • Cleveland-Cliffs Inc. CLF fell 13.6% to $7.26 after the company announced it will acquire AK Steel for approximately $3 billion.
  • Duluth Holdings Inc. DLTH dropped 11.5% to $8.01. Stifel Nicolaus maintained Duluth Holdings with a Hold and lowered the price target from $11 to $9.
  • Akari Therapeutics, Plc AKTX shares declined 11.1% to $1.92.
  • Plug Power Inc. PLUG fell 10.4% to $3.4039 after the company announced a 40 million share common stock offering.
  • NF Energy Saving Corporation BIMI shares tumbled 10% to $3.0527.
  • Tufin Software Technologies Ltd. TUFN dropped 9.1% to $17.35 after the company announced the launch of secondary public offering of ordinary shares.
  • Clovis Oncology, Inc. CLVS shares dipped 9.1% to $14.93.
  • Venator Materials PLC VNTR dropped 8.8% to $3.53.
  • Safe-T Group Ltd SFET dipped 8.7% to $5.60.
  • Adient plc ADNT fell 8.7% to $20.54.
  • TTEC Holdings Inc TTEC fell 8.1% to $41.11 after the company reported a 3 million share offering by selling shareholders.
  • RPC, Inc. RES fell 8% to $3.575.
  • Avita Medical Limited RCEL shares dropped 7.8% to $7.79.
  • Coupa Software Inc COUP shares fell 6.4% to $139.40 after the company reported Q3 earnings results.
  • Livongo Health, Inc. LVGO dipped 6% to $26.01 with the overall market on global macro concerns after Trump implied a US-China trade deal may not occur until 2020.
  • DouYu International Holdings Ltd DOYU dropped 5.1% to $7.13 after JP Morgan downgraded the company's stock from Overweight to Neutral and lowered the price target from $10 to $8.
Loading...
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralMid-Day GainersTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...